|

- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis
^. v$ _) s# F5 u" H5 Awas to close its brain research facility in Basel, Switzerland,. |" E a5 m- t2 |
the story noted that this move closely followed similar cuts
9 r1 M3 h# L" _5 G4 [0 Y4 n8 qby rival pharmaceutical firms. As a report from the European College
/ _1 b0 E) [7 X5 h3 {, Tof Neuropsychopharmacology
% M# D/ c# o& W. y6 }/ ~had warned a few months earlier, the
( G- B- _" R& X& T3 g# L; Xabandonment of research into new psychiatric drugs by AstraZeneca,6 v1 P: v+ l! O4 B% h$ i
GlaxoSmithKline
4 X- N5 q4 i% a4 Oand others meant that “withdrawal of research
* v0 T3 j% t- Xresources is a withdrawal of hope for patients and their families”.8 {5 v0 E+ V& D* G! y) x
. L* U G; Q K
, P$ ]; ^8 M+ u回复有免费下载链接
5 t6 v* I f1 \6 c4 i( t
+ r7 T( n8 f" P2 y4 A% S9 ? |
-
总评分: 包包 + 20
查看全部评分
|